Julia Haller

Haller attended the Bryn Mawr School. She received her A.B. from Princeton University, magna cum laude. She received her medical training at Harvard Medical School, followed by an internship at Johns Hopkins and a fellowship in ocular pathology at Manhattan Eye, Ear and Throat Hospital. Her residency was at the Wilmer Eye Institute at Johns Hopkins Hospital, followed by a retina fellowship at Hopkins. She was appointed the first female Chief Resident at Wilmer in 1986.

Haller became the inaugural Katharine Graham Professor of Ophthalmology at Wilmer Eye Institute in 2002. She also became the first holder of the Robert Bond Welch, M.D. Professorship of Ophthalmology there in 2006. At Wilmer, she directed the Retina Fellowship Training Program from 2001 to 2007.

In 2025, she became Chief Executive Officer of Wills Eye Hospital. In 2007, she became the Ophthalmologist-in-Chief of Wills Eye Hospital and co-director of the Wills Vision Research Center at Jefferson. She also is an attending surgeon at Children's Hospital of Philadelphia in the Division of Ophthalmology.

Haller is a member of the National Academy of Medicine, numerous international scientific advisory boards, and sits on the Board of Trustees of the Association of University Professors of Ophthalmology (AUPO), the College of Physicians of Philadelphia, and the Society of Heed Fellows. She is former president of the Women in Medicine Legacy Foundation. Haller joined the Board of Directors of Celgene In 2015 and Outlook Therapeutics in 2022.

She serves on the Board of the Johns Hopkins Medical and Surgical Association, and the Philadelphia Orchestra, and is a past member of the Board of Trustees of Princeton University.